Home/ Supplements/ Phosphorus/ CLA 2000 2000 mg

CLA 2000 2000 mg

product on market Softgel Capsule Zazzee Naturals Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 12% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The listed ingredients consist of basic macronutrients, which provide foundational energy and structural support for the body. Research on these components is extensive, though the specific evidence coverage for this product's formulation is limited. The profile maintains a high safety score with no significant concerns noted.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for CLA 2000 2000 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Softgel(s)
Serving Size
90
Servings
Fat/Fatty Acid
Product Type
12%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
14 Calorie(s)
Total Fat
2 Gram(s) (3% DV)
Cholesterol
Total Carbohydrate
Protein
0.46 Gram(s) (1% DV)
Calcium
12.6 mg (1% DV)
4.1 NP (1% DV)
Market median: 99.0mg (503 products) 13 studies (A:0, B:3)
Safflower Oil
2000 mg

Other Ingredients

Gelatin Glycerin Water, Purified
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Usage: As a dietary supplement, take 2 softgels, twice daily, between meals.

Warnings & Precautions

Allergen Information: Not manufactured with yeast, wheat, corn, gluten, soy, milk, egg, fish, shellfish or tree nuts ingredients. Produced in a GMP facility that processes other ingredients containing these allergens.

Warnings: For adults only.

Consult physician if pregnant or nursing.

Please consult with your healthcare provider before beginning any new supplement, diet, training program or if you are undergoing treatment for a medical condition.

Keep out of reach of children.

Do not eat freshness packet. Keep in bottle.

Formulation Notes

CLA contains conjugated linoleic acid (CLA), a unique optical isomer of the polyunsaturated fatty acid linoleic acid. The CLA in this formulation is derived from non-GMO safflower seed oil.

Allergen Information: Not manufactured with yeast, wheat, corn, gluten, soy, milk, egg, fish, shellfish or tree nuts ingredients.

2000 mg of safflower oil contains a minimum of 80% CLA (Conjugated Linoleic Acid).

Conjugated Linoleic Acid 2000 mg per serving

Weight management Supports healthy muscle tone Supports healthy lipid levels

Contains no artificial colors and flavors

Made with Non GMO ingredients

Additional Information

Please recycle.

GMP Good Manufacturing Practice Consistent quality Made in USA

Metadata

Product Details

UPC / SKUX0016AEDJX
DSLD Entry Date2022-10-24
Product TypeFat/Fatty Acid
FormSoftgel Capsule
DSLD ID276077
Data Updated2026-04-11
Research

Research Evidence

46
Research Sources
55
Avg Quality
23
Meta Analysis
7
Systematic Review
7
Rct
4
Clinical Trial
2
Other
1
Guideline
1
Regulatory Source
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
B Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
B Calcium and phosphorus supplementation of human milk for preterm infants
Systematic Review The Cochrane database of systematic reviews 2017 PubMed DOI
B Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
Meta Analysis Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2020 PubMed DOI
B ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
Guideline Clinical nutrition (Edinburgh, Scotland) 2018 PubMed DOI
B Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Annals of palliative medicine 2022 PubMed DOI
B Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of nephrology 2022 PubMed DOI
B Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies
Meta Analysis Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2024 PubMed DOI
View all evidence for Phosphorus →
Compare

Similar Products

View all Phosphorus products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.